Susquehanna International Group
SILO icon

Susquehanna International Group’s Silo Pharma SILO Stock Holding History

Susquehanna International Group’s Portfolio SILO Stock Details SILO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-4,186
Closed -$22.6K – 14424
2026
Q1 		$22.6K Buy
4,186
+2,214
+112% +$11.4K ﹤0.01% 12838
2025
Q4 		$10.1K Buy
+1,972
New +$14.6K ﹤0.01% 12057

Other funds holding SILO

AI
AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
HI
Harbour Investments Madison, Wisconsin $7.43B AUM 24.49% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Susquehanna International Group's SILO Position: Q2 2026 in Review

Susquehanna International Group sold out of Silo Pharma (SILO) in Q2 2026, closing a stake of 4,186 shares — an estimated $22.6K sold.

Susquehanna International Group first reported a position in SILO in Q4 2025 and held it in 2 quarters. The position peaked at $22.6K in Q1 2026. 9 funds tracked by Wall St. Rank hold SILO as of Q2 2026.

  • Susquehanna International Group reported no remaining Silo Pharma position as of Q2 2026 after selling out during the quarter.
  • Susquehanna International Group sold 4,186 Silo Pharma shares in Q2 2026, an estimated $22.6K.
  • Susquehanna International Group first reported a position in Silo Pharma in Q4 2025 and held it in 2 quarters.
  • Susquehanna International Group's Silo Pharma position peaked at $22.6K in Q1 2026.
  • 9 funds tracked by Wall St. Rank held Silo Pharma as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.